Kiwi Wealth Investments Limited Partnership’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36,065	Closed	-$2.32M	–	202
2023 Q2	$2.32M	Buy	36,065 +18,247	+102%	+$1.93M	0.14%	115
2023 Q1	$1.94M	Buy	17,818 +15,870	+815%	+$1.75M	0.13%	127
2022 Q4	$222K	Sell	1,948 -73,041	-97%	-$6.07M	0.01%	204
2022 Q3	$5.98M	Hold	74,989	–	–	0.41%	67
2022 Q2	$5.98M	Buy	+74,989	New	+$7.1M	0.41%	67

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's HZNP Position: Q3 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 36,065 shares — an estimated $2.32M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in HZNP in Q2 2022 and held it in 5 quarters. The position peaked at $5.98M in Q3 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Kiwi Wealth Investments Limited Partnership reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Kiwi Wealth Investments Limited Partnership sold 36,065 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $2.32M.
Kiwi Wealth Investments Limited Partnership first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 5 quarters.
Kiwi Wealth Investments Limited Partnership's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.98M in Q3 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.